[Greenlight(®) photoselective vaporisation for benign prostatic hyperplasia: a systematic review]

Area of Science:

• Urology
• Minimally Invasive Surgery
• Laser Technology

Background:

• Transurethral Resection of the Prostate (TURP) is the standard for complicated benign prostatic hyperplasia.
• Photoselective Vaporization (PVP) with Greenlight laser emerged to enhance hemostasis safety, especially for high-risk patients.
• This study reviews international literature on PVP outcomes.

Purpose of the Study:

• To systematically review the results of Photoselective Vaporization (PVP) for benign prostatic hyperplasia.
• To compare PVP outcomes with traditional Transurethral Resection of the Prostate (TURP).
• To assess the safety, efficacy, and functional results of PVP.

Main Methods:

• Systematic literature review on PubMed using keywords: benign prostatic hyperplasia, greenlight, photovaporisation, laser, IPSS score, endoscopic surgery, morbidity, complication.
• Inclusion of prospective and retrospective studies from 1998 onwards, in English and French.
• Selection criteria included studies reporting surgical technique, operative data, complications, functional results, or direct PVP vs. TURP comparisons.

Main Results:

• PVP demonstrates comparable medium-term functional results to TURP with a lower risk of bleeding.
• PVP does not appear to increase the risk of erectile dysfunction compared to TURP.
• PVP offers economic benefits through reduced hospital stay duration.

Conclusions:

• Photoselective Vaporization (PVP) with Greenlight laser is a safe and effective treatment for benign prostatic hyperplasia.
• Advancements in laser generators, like the XPS system, are maturing the PVP technique.
• Further long-term evaluations with high-level evidence are anticipated for PVP.